Citations

Clear

1727 citation(s) found for "Fu, Alan".

Absorption of water, sodium and potassium in small intestine of dogs
Code, Charles F., Bass, Paul , McClary, George B., Newnum, Raymond L., Orvis, Alan L.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 22, 2017 | Volume: 199 | Issue: 2 | Pages: 281-288

10.1152/ajplegacy.1960.199.2.281 | PMID 13694246 Get It

The rates of movement of isotopically labeled water, sodium and potassium from the contents of segments of duodenum and ileum into the blood (insorption) and from blood to the contents (exsorption) were determined in dogs. The insorption of labeled water and sodium from the duodenal and ileal segments was exponential in character. Calculation of insorption and exsorption using the exponential rate and the Visscher formulation gave similar values. Anesthesia produced by pentobarbital sodium had no effect on the insorption of water and sodium from the intestinal segments, but it caused a small decrease in exsorption into the duodenum. Acidification of the contents of the intestinal segments decreased insorption of water, sodium and potassium, whereas it increased the exsorption of sodium and potassium without altering that of water. The results indicate that the mucosa of the duodenum fulfills the function of equilibrating its contents by maintaining nearly equal and large movements of water and sodium in both directions, while that of the ileum is fixed to serve absorption (a net gain to the body) of water and sodium.
Compartment analysis of the radiorenogram and distribution of Hippuran I131 in dogs
Orvis, Alan L., Owen, Charles A., Blaufox, M. Donald

Mayo Clinic

American Journal of Physiology-Legacy Content | December 22, 2017 | Volume: 204 | Issue: 6 | Pages: 1059-1064

10.1152/ajplegacy.1963.204.6.1059 | PMID 13971569 Get It

Radioiodinated Hippuran was injected into the inferior vena cava of three unilaterally and three bilaterally nephrectomized dogs. Radioactivity was recorded over the precordium and remaining kidney in the former group and the precordium and renal fossa in the latter. The disappearance of I131 from plasma was analyzed and interpreted by two-compartment and three-compartment systems. Theoretical curves for cardiac and renal areas (constructed from analysis of arterial plasma samples) agreed well with curves from in vivo counting. Analyzed by either model, the first compartment exceeded the plasma volume severalfold, part seeming to be in the kidney. Extravascular compartments, impossible to sample, were not identified. About 15% of whole-blood radioactivity was in erythrocytes. Biliary excretion of Hippuran I131 was insignificant unless nephrectomy was bilateral; then up to 60% was excreted in the bile in 24 hr. Protein binding could not be demonstrated. Radiorenograms converted to fairly accurate rate constants may prove more useful than descriptive methods currently employed. Understanding the distribution and excretion of Hippuran appears helpful to accurate interpretation of the radiorenogram.
Metabolism of L-Thyroxine and L-Triiodothyronine in the Absence of the Liver
Flock, Eunice V., Bollman, Jesse L., Grindlay, John H., Orvis, Alan L.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 21, 2017 | Volume: 187 | Issue: 3 | Pages: 407-414

10.1152/ajplegacy.1956.187.3.407 | PMID 13402895 Get It

The total amount of I131-containing compounds excreted in the urine of the dehepatized dog receiving either radioactive thyroxine or triiodothyronine is similar to that of the normal dog receiving similar injections. The important role of the liver in the deiodination of thyroxine and triiodothyronine is indicated by the failure of the liverless animal to convert these compounds to inorganic iodide as completely as does the normal dog. Only a small percentage of the I131 compounds excreted by the liverless dog appears as inorganic iodide. The most abundant iodine compound in the urine of the dehepatized dog is a conjugate of thyroxine when thyroxine is injected, and an unidentified compound, b, when triiodothyronine is injected.
Plasmatic diatrizoate-I131 disappearance and glomerular filtration in the dog
Tauxe, W. Newlon, Wakim, Khalil G., Orvis, Alan L., Owen, Charles A., Blaufox, M. Donald , Sanderson, David

Mayo Clinic

American Journal of Physiology-Legacy Content | December 21, 2017 | Volume: 204 | Issue: 4 | Pages: 536-540

10.1152/ajplegacy.1963.204.4.536 | PMID 13971566 Get It

A study was made of the disappearance of sodium diatrizoate-I131 from the plasma of ten dogs after single intravenous injections. The plasma disappearance curves suggested a two-compartment system. The renal plasma clearance of diatrizoate-I131 calculated from these curves and the conventional renal plasma clearance of creatinine were not statistically different. Clearances calculated from the urinary excretion and midperiod plasma concentration of radioactivity in four experiments yielded values averaging 10% less than the creatinine clearance. Chromatographic studies of commercially available diatrizoate-I131 revealed the presence of about 5% free iodide and of about 5% of unidentified impurities. These impurities seem to account, partly at least, for the differences found between diatrizoate clearance and creatinine clearance. Biliary excretion and erythrocytic uptake of diatrizoate were minimal and did not appear to influence the analysis.
Rate of loss of radioiron from mouse and man
Bonnet, John D., Orvis, Alan L., Hagedorn, Albert B., Owen, Charles A.

Mayo Clinic

American Journal of Physiology-Legacy Content | December 21, 2017 | Volume: 198 | Issue: 4 | Pages: 784-786

10.1152/ajplegacy.1960.198.4.784 | PMID 13802571 Get It

Forty-two male and female mice, 8 weeks old, were given radioiron (Fe59) in doses of 0.006–0.1 µc, containing 0.013–0.17 µg of iron, by intraperitoneal or intravenous routes. Assays of the radioactivity of the whole body revealed an initial rapid loss of Fe59 (15–20%) lasting about 6 days. Thereafter the Fe59 left the mice at a steady rate of 0.39%/day (half-life 180 days). One 34-year-old normal man was given 10.6 µc of Fe59, containing 8.2 µg of iron, intravenously. Based on counts from the entire body, the biologic rate of loss of the Fe59 was about 0.14%/day (half-life 500 days), and there was little or no initial loss such as occurred in the mouse. The Fe59 in the circulating erythrocytes was essentially unchanged for the first 3 months. It then fell to a new level of about 90% of the previous one; the mid-point of the fall was about 120 days after the administration of the radioiron. The difference in the rates of loss of radioiron from mice and man seems to be related primarily to the life span of the circulating red cells.
Disease Modeling Studies Using Induced Pluripotent Stem Cells: Are we Using Enough Controls?
Johnson, Adiv A. , Andrews‐Pfannkoch, Cynthia, Pulido, José S. , Marmorstein, Alan D. , Nelson, Timothy J. , Marmorstein, Alan D

Mayo Clinic

Regenerative Medicine | December 15, 2017 | Volume: 12 | Issue: 8 | Pages: 899-903

10.2217/rme-2017-0101 | PMID 29243553 Get It

Semantics-oriented data science and computational life sciences: Innovative application of semantic technologies in microRNA and lncRNA research
Huang, Jingshan , Dou, Dejing , Eilbeck, Karen , Tan, Ming , Borchert, Glen Mark , Ruttenberg, Alan , Yang, Ping

Mayo Clinic

2017 IEEE 7th International Conference on Computational Advances in Bio and Medical Sciences (ICCABS) | November 20, 2017 | Volume: No volume available | Issue: No issue available | Pages: 1-1

10.1109/iccabs.2017.8114284 Get It

Architectural T-Wave Analysis and Identification of On-Therapy Breakthrough Arrhythmic Risk in Type 1 and Type 2 Long-QT Syndrome
Sugrue, Alan , Rohatgi, Ram K., Křemen, Václav , Bos, J. Martijn , Qiang, Bo , Sapir, Yehu , Brady, Peter A. , Asirvatham, Samuel J. , Friedman, Paul A. , Ackerman, Michael J. , Asirvatham, Samuel J , Kremen, Vaclav , Bos, Johan M , Noseworthy, Peter A. , Attia, Zachi I. , Scott, Christopher G.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | November 16, 2017 | Volume: 10 | Issue: 11 | Pages: No page available

10.1161/circep.117.005648 | PMID 29141844 Get It

Background: Although the hallmark of long-QT syndrome (LQTS) is abnormal cardiac repolarization, there are varying degrees of phenotypic expression and arrhythmic risk. Our aim was to evaluate the performance of a morphological T-wave analysis program in defining breakthrough LQTS arrhythmic risk beyond the QTc value. Methods and Results: We analyzed 407 genetically confirmed patients with LQT1 (n=246; 43% men) and LQT2 (n=161; 41% men) over the mean follow-up period of 6.4±3.9 years. ECG analysis was conducted using a novel, proprietary T-wave analysis program. Time to a LQTS-associated cardiac event was analyzed using Cox proportional hazards regression methods. Twenty-three patients experienced ≥1 defined breakthrough cardiac arrhythmic events with 5- and 10-year event rates of 4% and 7%. Two independent predictors of future LQTS-associated cardiac events from the surface ECG were identified: left slope of T wave in lead V6 (hazard ratio=0.40 [0.24–0.69]; P <0.001) and T-wave center of gravity x axis (last 25% of wave) in lead I (hazard ratio=1.90 [1.21–2.99]; P =0.005), C statistic of 0.77 (0.65–0.89). When added to the QTc (C statistic 0.68 for QTc alone), discrimination improved to 0.78. Genotype analysis showed weaker association between these T-wave variables and LQT1-triggered events while these features were stronger in patients with LQT2 and significantly outperformed the QTc (C statistic, 0.82 [0.71–0.93]). Conclusion: Detailed morphological analysis of the T wave provides novel insights into risk of breakthrough arrhythmic events in LQTS, particularly LQT2. This observation has the potential to guide clinical decision making and further refine risk stratification.
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Imp
Peterson, Pamela N., Greenlee, Robert T. , Go, Alan S. , Magid, David J. , Garcia‐Montilla, Romel , Glenn, Karen A., Gurwitz, Jerry H. , Hammill, Stephen C., Hayes, John, Kadish, Alan H. , Sharma, Param , Smith, David H. , Varosy, Paul D. , Vidaillet, Humberto, Zeng, Chan , Masoudi, Frederick A. , Peterson, Pamela N. , Cassidy‐Bushrow, Andrea E. , Reynolds, Kristi , Normand, Sharon‐Lise T.

Mayo Clinic

Journal of the American Heart Association | November 10, 2017 | Volume: 6 | Issue: 11 | Pages: No page available

10.1161/jaha.117.006937 | PMID 29122811 Get It

Background In US clinical practice, many patients who undergo placement of an implantable cardioverter‐defibrillator ( ICD ) for primary prevention of sudden cardiac death receive dual‐chamber devices. The superiority of dual‐chamber over single‐chamber devices in reducing the risk of inappropriate ICD shocks in clinical practice has not been established. The objective of this study was to compare risk of adverse outcomes, including inappropriate shocks, between single‐ and dual‐chamber ICD s for primary prevention. Methods and Results We identified patients receiving a single‐ or dual‐chamber ICD for primary prevention who did not have an indication for pacing from 15 hospitals within 7 integrated health delivery systems in the Longitudinal Study of Implantable Cardioverter‐Defibrillators from 2006 to 2009. The primary outcome was time to first inappropriate shock. ICD shocks were adjudicated for appropriateness. Other outcomes included all‐cause hospitalization, heart failure hospitalization, and death. Patient, clinician, and hospital‐level factors were accounted for using propensity score weighting methods. Among 1042 patients without pacing indications, 54.0% (n=563) received a single‐chamber device and 46.0% (n=479) received a dual‐chamber device. In a propensity‐weighted analysis, device type was not significantly associated with inappropriate shock (hazard ratio, 0.91; 95% confidence interval, 0.59–1.38 [ P =0.65]), all‐cause hospitalization (hazard ratio, 1.03; 95% confidence interval, 0.87–1.21 [ P =0.76]), heart failure hospitalization (hazard ratio, 0.93; 95% confidence interval, 0.72–1.21 [ P =0.59]), or death (hazard ratio, 1.19; 95% confidence interval, 0.93–1.53 [ P =0.17]). Conclusions Among patients who received an ICD for primary prevention without indications for pacing, dual‐chamber devices were not associated with lower risk of inappropriate shock or differences in hospitalization or death compared with single‐chamber devices. This study does not justify the use of dual‐chamber devices to minimize inappropriate shocks.
Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study
Zinsmeister, Alan R., Herrick, Linda M., Saito, Yuri A. , Schleck, Cathy D. , Saito Loftus, Yuri A, Talley, Nicholas J.

Mayo Clinic

Scandinavian Journal of Gastroenterology | November 6, 2017 | Volume: 53 | Issue: 5 | Pages: 549-558

10.1080/00365521.2017.1395908 | PMID 29103329 Get It